Scanfil has signed a new manufacturing outsourcing agreement with Liquid Instruments, strengthening its presence in Australia’s Medtech and Life Science manufacturing sector.
Under the agreement, production of Liquid Instruments’ flagship Moku platform will be onshored to Scanfil’s Melbourne facility.
The partnership supports Liquid Instruments’ efforts to localise its supply chain and enhance operational efficiency by bringing manufacturing closer to its research and development base.
The collaboration also aligns with broader national goals to bolster domestic production in advanced technology sectors.
“We’re continuing to expand our manufacturing footprint in Australia,” said Daniel Shaddock, CEO of Liquid Instruments.
“Onshoring production through this partnership allows us to scale more efficiently, while deepening our investment in Australia’s technology ecosystem. Scanfil’s expertise and strong local presence make them the ideal partner for this next phase of growth.”
Scanfil, through its subsidiary SRXGlobal, will provide Liquid Instruments with a suite of services including supply chain management, scalable manufacturing, global delivery, and aftermarket support—all based in Victoria.
The move is expected to enhance Liquid Instruments’ ability to meet growing demand for its innovative test and measurement platform.
“Liquid Instruments has developed a unique product with an interesting and complex technology that is a perfect fit for the services provided by SRXGlobal in Australia,” said Christian Kesten, vice president of Scanfil APAC.
“We at Scanfil and SRXGlobal are thrilled and excited that Liquid Instruments has chosen SRXGlobal as their preferred manufacturing partner for the exciting journey ahead, and we look forward to a strong and successful partnership.”
Scanfil is Europe’s largest listed provider of electronics manufacturing services (EMS), with a 2024 turnover of EUR 780 million.
The company operates eleven production facilities across four continents and serves global leaders in sectors such as Industrial, Energy & Cleantech, and Medtech & Life Science.
